GSTM1 and acute monocytic leukemia: The acute monocytic leukemia (THP1) cell model was selected for the production of the CRISPR–Cas9 GSTM1- and/or GSTT1 knockout model, as we have the most patients with a relapsed AML (Supplementary Table 3).